Panacea Biotec inaugurates Oncology facility in Himachal Pradesh

28 Mar 2012 Evaluate

Panacea Biotec, India's leading vaccine manufacturer has inaugurated its new state-of-the-art Oncology facility at Baddi in Himachal Pradesh to meet the growing demand of anti-cancer products in the country.

The new manufacturing facility will entail an annual production of about 1.2 million vials, and being set up in compliance with various international regulatory standards like CGMP, USFDA and UK-MHRA. The plant has been set up with a project cost of about Rs 55 crore.

The company has been aggressively ramping up its production capacity, as well as introducing new business lines to cater to emerging business opportunities in various therapeutic segments. The company has released products for sales from commercial production from March 2012.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

133.95 -1.75 (-1.29%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.